Paying users zone. Data is hidden behind: .
Get 1-month access to Medtronic PLC for $19.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Medtronic PLC pages available today for free:
Enterprise Value to EBITDA (EV/EBITDA)
Earnings before Interest, Tax, Depreciation and Amortization (EBITDA)
Medtronic PLC, EBITDA calculation
US$ in millions
Based on: 10-K (filing date: 2020-06-19), 10-K (filing date: 2019-06-21), 10-K (filing date: 2018-06-22), 10-K (filing date: 2017-06-27), 10-K (filing date: 2016-06-28), 10-K (filing date: 2015-06-23).
Item | Description | The company |
---|---|---|
EBITDA | To calculate EBITDA analysts start with net earnings. To that earnings number, interest, taxes, depreciation, and amortization are added. EBITDA as a pre-interest number is a flow to all providers of capital. | Medtronic PLC’s EBITDA decreased from 2018 to 2019 and from 2019 to 2020. |
Enterprise Value to EBITDA Ratio, Current
Medtronic PLC, current EV/EBITDA calculation, comparison to benchmarks
Selected Financial Data (US$ in millions) | |
Enterprise value (EV) | |
Earnings before interest, tax, depreciation and amortization (EBITDA) | |
Valuation Ratio | |
EV/EBITDA | |
Benchmarks | |
EV/EBITDA, Competitors1 | |
Becton, Dickinson & Co. | |
Boston Scientific Corp. | |
Danaher Corp. | |
Edwards Lifesciences Corp. | |
Intuitive Surgical Inc. | |
Stryker Corp. | |
Thermo Fisher Scientific Inc. | |
UnitedHealth Group Inc. | |
EV/EBITDA, Sector | |
Health Care Equipment & Services | |
EV/EBITDA, Industry | |
Health Care |
Based on: 10-K (filing date: 2020-06-19).
1 Click competitor name to see calculations.
If the company EV/EBITDA is lower then the EV/EBITDA of benchmark then company is relatively undervalued.
Otherwise, if the company EV/EBITDA is higher then the EV/EBITDA of benchmark then company is relatively overvalued.
Enterprise Value to EBITDA Ratio, Historical
Medtronic PLC, historical EV/EBITDA calculation, comparison to benchmarks
Apr 24, 2020 | Apr 26, 2019 | Apr 27, 2018 | Apr 28, 2017 | Apr 29, 2016 | Apr 24, 2015 | ||
---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||
Enterprise value (EV)1 | |||||||
Earnings before interest, tax, depreciation and amortization (EBITDA)2 | |||||||
Valuation Ratio | |||||||
EV/EBITDA3 | |||||||
Benchmarks | |||||||
EV/EBITDA, Competitors4 | |||||||
Becton, Dickinson & Co. | |||||||
Boston Scientific Corp. | |||||||
Danaher Corp. | |||||||
Edwards Lifesciences Corp. | |||||||
Intuitive Surgical Inc. | |||||||
Stryker Corp. | |||||||
Thermo Fisher Scientific Inc. | |||||||
UnitedHealth Group Inc. | |||||||
EV/EBITDA, Sector | |||||||
Health Care Equipment & Services | |||||||
EV/EBITDA, Industry | |||||||
Health Care |
Based on: 10-K (filing date: 2020-06-19), 10-K (filing date: 2019-06-21), 10-K (filing date: 2018-06-22), 10-K (filing date: 2017-06-27), 10-K (filing date: 2016-06-28), 10-K (filing date: 2015-06-23).
3 2020 Calculation
EV/EBITDA = EV ÷ EBITDA
= ÷ =
4 Click competitor name to see calculations.
Valuation ratio | Description | The company |
---|---|---|
EV/EBITDA | Enterprise value to earnings before interest, tax, depreciation and amortization is a valuation indicator for the overall company rather than common stock. | Medtronic PLC’s EV/EBITDA ratio increased from 2018 to 2019 and from 2019 to 2020. |